½ÃÀ庸°í¼­
»óǰÄÚµå
1594675

¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå : Á¦Ç° À¯Çü, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Optical Coherence Tomography for Ophthalmology Market by Product (Catheter-based OCT Devices, Doppler OCT Devices, Handheld OCT Devices), Type (Fully Automatic, Semi-Automatic), Technology, End user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀåÀº 2023³â 25¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 29¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 17.19% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 77¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ(OCT)Àº ¸Á¸·ÀÇ °íÇØ»óµµ ´Ü¸é ¿µ»óÀ» Á¦°øÇϴ ȹ±âÀûÀÎ ¿µ»ó ±â¼ú·Î, ³ì³»Àå, ³ëÈ­¼º Ȳ¹Ýº¯¼º(AMD), ´ç´¢¸Á¸·º´Áõ µî ´Ù¾çÇÑ ¾È°ú ÁúȯÀÇ Áø´Ü, ¸ð´ÏÅ͸µ, °ü¸® ¹× Ä¡·á °èȹÀÇ Á¤È®¼ºÀ» ³ôÀÌ´Â µ¥ ÇÊ¿äÇÑ ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß·Î Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. OCTÀÇ ÃÖÁ¾ ¿ëµµ´Â º´¿ø, ¾È°ú Àü¹® Ŭ¸®´Ð, ¿¬±¸¼Ò µî ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº Àü ¼¼°è ¾ÈÁúȯÀÇ Áõ°¡, ½ºÆåÆ®·³ µµ¸ÞÀÎ OCT ¹× ½ºÀ§ÇÁ±¤¿ø OCT¿Í °°Àº OCT ±â¼úÀÇ ¹ßÀü, ½Ã·Â °ü·Ã ¹®Á¦°¡ ¹ß»ýÇϱ⠽¬¿î °í·ÉÈ­ »çȸ µîÀÌ ÀÖ½À´Ï´Ù. ½ÅÈï±¹ÀÇ ÇコÄɾî ÀÎÇÁ¶ó È®´ë´Â ¸Å·ÂÀûÀÎ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê°ú Áø´Ü ´É·ÂÀ» Çâ»ó½ÃŰ°í ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÒ ¼ö ÀÖ´Â OCT ½Ã½ºÅÛ¿¡ AI ÅëÇÕÀ» µµÀÔÇÔÀ¸·Î½á ÀáÀçÀûÀÎ ¼ºÀå ÀáÀç·ÂÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿©Á¤¿¡µµ ºÒ±¸Çϰí, OCT ÀåºñÀÇ ³ôÀº ºñ¿ë°ú »óȯ ¹®Á¦´Â Å« Á¦¾à°ú °úÁ¦·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÈÄÁø±¹ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡ ´ëÇÑ ÀνÄÀÌ ºÎÁ·ÇØ ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¹°À» ±Øº¹Çϱâ À§ÇØ ±â¾÷µéÀº ºñ¿ë È¿À²ÀûÀÎ ±â¼ú Çõ½Å¿¡ ÁýÁßÇØ¾ß Çϸç, ¾Æ¸¶µµ ¸ðµâ½Ä ¼³°è¿Í ÇÚµåÇïµå ±â±â¸¦ ÅëÇØ OCT¸¦ º¸´Ù Ä£¼÷ÇÏ°Ô ¸¸µé ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ÈÞ´ë¿ë OCT ½Ã½ºÅÛÀ» °³¹ßÇϸé ÀÌ ±â¼úÀÌ Áö¹æÀ̳ª ¹Ì°³Ã´ Áö¿ªÀ¸·Î È®ÀåµÇ¾î ¹Ì°³Ã´ ȯÀÚ±ºÀ» ¹ß°ßÇÒ ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù. ±â°èÇнÀ ±â¹Ý ºÐ¼®¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÀüµÇ¸é Á¤¹Ð Áø´ÜÀÇ ÇѰ踦 ¶Ù¾î³Ñ¾î ±â¾÷ÀÌ ½ÃÀå Â÷º°È­¸¦ À§ÇØ È°¿ëÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ °³Ã´Áö¸¦ Á¦½ÃÇÒ ¼ö ÀÖÀ¸¸ç, OCT ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏÁö¸¸ ÷´Ü ±â¼ú°ú ºñ¿ë È¿À²¼º ¹× ½Ç¿ëÀûÀÎ ÀÀ¿ëÀ» °áÇÕÇÒ ¼ö ÀÖ´Â Çõ½Å°¡¿¡°Ô´Â ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú À¶ÇÕ°ú ¾È°ú Àα¸Åë°èÇÐÀû Ãß¼¼¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ´Â Çõ½Å°¡µé¿¡°Ô ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 25¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 29¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 77¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 17.19%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ´ç´¢º´ °ü·Ã ¸Á¸·Áõ°ú ³ì³»ÀåÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡
    • ¾È±¸ °ü·Ã Áúȯ¿¡ ´ëÇÑ Á¤ºÎÀÇ ¿ì´ë Á¤Ã¥
    • ¾È°ú ÁúȯÀÇ Á¶±â Áø´Ü¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ ¹× ÁöÃâ Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ¾È°ú ¼Ö·ç¼Ç¿ë OCT °ü·Ã ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ÃÖ¼Òħ½ÀÀû ¼ö¼ú ¹× Áø´Ü ±â¹ý¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡
    • ¾È°ú¿ë OCTÀÇ Áö¼ÓÀûÀÎ ¹ßÀü
  • ½ÃÀå °úÁ¦
    • º¸°ÇÀÇ·á »ê¾÷ Àü¹Ý¿¡ °ÉÃÄ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·

Porter's Five Forces : ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå¿¡¼­ ¿ÜºÎÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå¿¡¼­ º¥´õÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ

¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ±â¾÷Àº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå : Á¦Ç°º°

  • Ä«Å×ÅÍ ±â¹Ý OCT µð¹ÙÀ̽º
  • µµÇ÷¯ OCT Àåºñ
  • ÇÚµåÇïµå OCT µð¹ÙÀ̽º
  • Ź»ó OCT Àåºñ

Á¦7Àå ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå : À¯Çüº°

  • ¿ÏÀü ÀÚµ¿
  • ¹ÝÀÚµ¿

Á¦8Àå ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå : ±â¼úº°

  • Á֯ļö ¿µ¿ª OCT
  • °ø°£ ¾Ïȣȭ Á֯ļö OCT
  • ½Ã°£ ¿µ¿ª OCT

Á¦9Àå ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø¡¤Å¬¸®´Ð
  • ÀÇ»ç ¿ÀÇǽº

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾È°ú¿ë ±¤°£¼·´ÜÃþÃÔ¿µ±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • Conavi Medical Inc.
  • Excelitas Technologies Corp.
  • HAAG-STREIT GROUP
  • Heidelberg Engineering Inc.
  • Luneau Technology USA
  • Novacam Technologies, Inc.
  • OPTOPOL Technology Sp. z o.o.
  • Santec Corporation
  • Sonostar Technologies Co., Limited
  • Thorlabs, Inc.
  • Topcon Corporation
  • ZD Medical Inc.
ksm 24.11.28

The Optical Coherence Tomography for Ophthalmology Market was valued at USD 2.55 billion in 2023, expected to reach USD 2.98 billion in 2024, and is projected to grow at a CAGR of 17.19%, to USD 7.76 billion by 2030.

Optical Coherence Tomography (OCT) for ophthalmology represents a transformative imaging technology providing high-resolution cross-sectional images of the retina. The scope of OCT extends to its necessity in diagnosing, monitoring, and managing a wide array of ocular conditions, such as glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy, enhancing precision in treatment plans. The application of OCT is broad, with end-use sectors including hospitals, specialized ophthalmic clinics, and research laboratories. Market growth is driven by increasing incidences of eye disorders globally, advancements in OCT technology like spectral-domain and swept-source OCT, and the aging population, which is more susceptible to vision-related issues. An expanding healthcare infrastructure in emerging economies presents compelling opportunities. Potential growth can be harnessed through strategic partnerships with healthcare providers and adopting AI integration in OCT systems, which can enhance diagnostic capabilities and streamline workflow. Despite these growth avenues, the high cost of OCT devices and reimbursement challenges pose significant limitations and challenges. Inadequate awareness among both practitioners and patients in less developed regions further throttles market expansion. To navigate these hurdles, companies should focus on cost-effective innovations, possibly through modular designs or handheld devices, making OCT more accessible. Additionally, the development of portable OCT systems could extend the technology's reach into rural and underserved areas, unveiling untapped patient populations. Further research into machine learning-based analysis could also push the envelope in precision diagnostics, marking an innovation frontier that businesses can exploit for market differentiation. The nature of the OCT market is competitive yet primed for innovators who can blend cutting-edge technology with cost-efficiency and practical applications, positioning themselves to leverage technological convergence and demographic trends in ophthalmology.

KEY MARKET STATISTICS
Base Year [2023] USD 2.55 billion
Estimated Year [2024] USD 2.98 billion
Forecast Year [2030] USD 7.76 billion
CAGR (%) 17.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Optical Coherence Tomography for Ophthalmology Market

The Optical Coherence Tomography for Ophthalmology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of diabetes-related retinopathy and glaucoma globally
    • Favorable governmental reimbursement policies for eye-related disorders
    • Rising consumer preference and expenditures for early diagnosis for ophthalmologic disorders
  • Market Restraints
    • High cost associated with OCT for ophthalmology solutions
  • Market Opportunities
    • Growing preference for minimally-invasive surgical and diagnostic procedures
    • Ongoing advancements in OCT for ophthalmologic procedures
  • Market Challenges
    • Scarcity of skilled professionals across the healthcare vertical

Porter's Five Forces: A Strategic Tool for Navigating the Optical Coherence Tomography for Ophthalmology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Optical Coherence Tomography for Ophthalmology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Optical Coherence Tomography for Ophthalmology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Optical Coherence Tomography for Ophthalmology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Optical Coherence Tomography for Ophthalmology Market

A detailed market share analysis in the Optical Coherence Tomography for Ophthalmology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Optical Coherence Tomography for Ophthalmology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Optical Coherence Tomography for Ophthalmology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Optical Coherence Tomography for Ophthalmology Market

A strategic analysis of the Optical Coherence Tomography for Ophthalmology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Optical Coherence Tomography for Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Conavi Medical Inc., Excelitas Technologies Corp., HAAG-STREIT GROUP, Heidelberg Engineering Inc., Luneau Technology USA, Novacam Technologies, Inc., OPTOPOL Technology Sp. z o.o., Santec Corporation, Sonostar Technologies Co., Limited, Thorlabs, Inc., Topcon Corporation, and ZD Medical Inc..

Market Segmentation & Coverage

This research report categorizes the Optical Coherence Tomography for Ophthalmology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Catheter-based OCT Devices, Doppler OCT Devices, Handheld OCT Devices, and Tabletop OCT Devices.
  • Based on Type, market is studied across Fully Automatic and Semi-Automatic.
  • Based on Technology, market is studied across Frequency Domain OCT, Spatial Encoded Frequency OCT, and Time Domain OCT.
  • Based on End user, market is studied across Ambulatory Surgery Centers, Hospital & Clinics, and physicians' Offices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of diabetes-related retinopathy and glaucoma globally
      • 5.1.1.2. Favorable governmental reimbursement policies for eye-related disorders
      • 5.1.1.3. Rising consumer preference and expenditures for early diagnosis for ophthalmologic disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with OCT for ophthalmology solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing preference for minimally-invasive surgical and diagnostic procedures
      • 5.1.3.2. Ongoing advancements in OCT for ophthalmologic procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals across the healthcare vertical
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Optical Coherence Tomography for Ophthalmology Market, by Product

  • 6.1. Introduction
  • 6.2. Catheter-based OCT Devices
  • 6.3. Doppler OCT Devices
  • 6.4. Handheld OCT Devices
  • 6.5. Tabletop OCT Devices

7. Optical Coherence Tomography for Ophthalmology Market, by Type

  • 7.1. Introduction
  • 7.2. Fully Automatic
  • 7.3. Semi-Automatic

8. Optical Coherence Tomography for Ophthalmology Market, by Technology

  • 8.1. Introduction
  • 8.2. Frequency Domain OCT
  • 8.3. Spatial Encoded Frequency OCT
  • 8.4. Time Domain OCT

9. Optical Coherence Tomography for Ophthalmology Market, by End user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Hospital & Clinics
  • 9.4. physicians' Offices

10. Americas Optical Coherence Tomography for Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Optical Coherence Tomography for Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Optical Coherence Tomography for Ophthalmology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Canon Medical Systems Corporation
  • 3. Carl Zeiss Meditec AG
  • 4. Conavi Medical Inc.
  • 5. Excelitas Technologies Corp.
  • 6. HAAG-STREIT GROUP
  • 7. Heidelberg Engineering Inc.
  • 8. Luneau Technology USA
  • 9. Novacam Technologies, Inc.
  • 10. OPTOPOL Technology Sp. z o.o.
  • 11. Santec Corporation
  • 12. Sonostar Technologies Co., Limited
  • 13. Thorlabs, Inc.
  • 14. Topcon Corporation
  • 15. ZD Medical Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦